Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000336278 | SCV000479595 | uncertain significance | Hyper-IgE syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003595941 | SCV001045037 | benign | Autosomal recessive hyper-IgE syndrome | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821121 | SCV002072293 | likely benign | not specified | 2021-04-13 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003430969 | SCV004161702 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | DOCK8: BP4, BS2 |
Prevention |
RCV003957869 | SCV004772445 | likely benign | DOCK8-related disorder | 2019-08-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |